Electrochemical sensor based on molecularly imprinted polymer cryogel and multiwalled carbon nanotubes for direct insulin detection

Biomimetic Polythiophene: g-C3N4 Nanotube Composites with Induced Creatinine and Uric Acid Specificity for Portable CKD and Gout Detection

Despite significant advancements in disease diagnostics, the development of portable, highly selective, and low-cost electrochemical sensors for real-time, noninvasive detection of chronic kidney disease (CKD) and gout biomarkers remains a challenge. In this work, we demonstrate an inexpensive CKD and gout diagnostic platform with the incorporation of biomimetic polymer matrix nanocomposites based on creatinine (CRE) and uric acid (UA) imprinted conducting polythiophene (MIP) and graphitic carbon nitride nanotubes (NTs). These nanocomposites are termed CRE-MIPNT or UA-MIPNT, depending on the template. Disposable electrochemical devices are fabricated by anchoring CRE-MIPNT or UA-MIPNT nanocomposites on screen-printed Au microelectrodes. The surface micrographs exhibit the integration of NTs in the polymer matrix, resulting in highly leptokurtic surfaces. Consequently, the charge transfer resistance at the electrode-electrolyte interface is significantly reduced, as characterized by electrochemical impedance spectroscopy. An increase in the electroactive surface area and charge transfer kinetics is also observed for the CRE-MIPNT/Au-SPE and UA-MIPNT/Au-SPE sensors. In comparison to nonimprinted sensors, their performance is investigated in terms of their voltammetric response toward various biomarker concentrations in standard redox solutions. The sensitivity in the CV measurements is 0.59 μA cm-2 nM-1 for CRE-MIPNT/Au-SPE and 0.78 μA cm-2 μM-1 for UA-MIPNT/Au-SPE sensors, with detection limits of 390 pM and 162 nM for CRE and UA, respectively. The sensors demonstrate high selectivity toward the target analytes while showing minimal interference from other metabolites. Moreover, recovery rates for spiked saliva samples ranged between 97 and 102%, which indicates the reliability of the sensor for real-world applications.

Theranostic advances and the role of molecular imprinting in disease management

Molecular imprinting has become an effective technology in the realm of diagnosing diseases, providing unparalleled specificity and sensitivity. This method is a promising trend in current medical research. This review examines the utilization of molecularly imprinted polymers (MIPs) in theranostic that integrates diagnostic functionalities for personalized medicine. The present work briefly discusses the fundamental concepts of molecular imprinting and how it has evolved into a versatile platform. Subsequently, the utilization of MIPs in the advancement of biosensors is focused, specifically emphasizing their contribution to the detection and diagnosis of diseases. The therapeutic potential of MIPs, focusing on targeted drug delivery and controlled release systems and the integration of MIPs into theranostic platforms is explored through case studies, showcasing the technology's ability to simultaneously diagnose and treat diseases. Finally, we address the current challenges facing MIPs and discuss future perspectives, emphasizing the potential of this technology to revolutionize the next generation.

Molecular Imprinted Polymer Decorated Electrochemical Sensors for Diabetes Biomarkers: A Critical Review

Diabetes is a chronic illness marked by high blood sugar or hyperglycemia, which can be caused by deficiencies in the action or secretion of insulin, or both. A prolonged period of elevated blood glucose levels can cause several tissues to malfunction. To avoid or postpone the onset of problems associated with diabetes, early diagnosis, and effective care are essential. Biomarkers and biosensors have become potential tools for monitoring and managing diabetes. Glucose, glycated hemoglobin, and other relevant biomarkers of diabetes can be detected using various biosensors, including enzymatic, electrochemical, and optical types. The molecular imprinting technique is an emerging electroanalytical method, that creates cavities in the polymer matrix with an affinity for a selected template molecule, known as molecularly imprinted polymer (MIP). Typically, the procedure involves the polymerization of monomers in the presence of a template molecule, which is then removed to leave behind imprinting sites. These polymers have been employed in molecular sensors, chemical separations, and catalysis due to their affinity for the original molecule. With special attention to their mechanisms of action, clinical applications, limitations, and the potential of emerging technologies, such as wearables and nano-biosensors, these can be used for continuous and real-time diabetes monitoring. This critical review focuses on the role of nanomaterials and conducting polymer-decorated molecularly imprinted sensors for tracking diabetes biomarkers. Additionally, this paper discusses the difficulties in developing and implementing biosensors, including selectivity, sensitivity, and real-time monitoring of glucose levels.

Electrochemical biosensors for enhanced detection of diabetes mellitus

The worldwide incidence of diabetes mellitus (DM), as a long-term metabolic condition, continues to rise, creating an urgent need for accurate and efficient diagnostic methods to identify and treat the disease early. Among various analytical technologies, electrochemical biosensors stand out for their exceptional attributes, including precise detection, selective response, quick results, and affordable implementation. The current review study examines the latest developments in electrochemical biosensor technology designed specifically for diabetes detection, emphasizing novel approaches in blood sugar monitoring and tracking key diabetes indicators, including HbA1c, insulin levels, and ketones. The discussion encompasses cutting-edge developments such as sensors incorporating nanomaterials, non-enzymatic detection systems, and portable monitoring devices, emphasizing how these innovations improve both technical capabilities and patient experience. This review also demonstrates how next-generation electrochemical biosensors could fundamentally change diabetes care and monitoring, leading to more widely available and accurate disease tracking methods.

Porogenic Solvents in Molecularly Imprinted Polymer Synthesis: A Comprehensive Review of Current Practices and Emerging Trends

The versatility of molecularly imprinted polymers (MIPs) has led to their integration into applications like biosensing, separation, environmental monitoring, and drug delivery technologies. This diversity of applications has resulted in a plethora of synthesis approaches to precisely tailor the materials' properties to the specific demands. A critical, yet often overlooked, factor in MIP synthesis is the choice of porogen. Porogens play a pivotal role in defining the morphology, surface properties, swelling behavior, and binding efficiencies of the resulting MIPs. While aprotic solvents have traditionally been the standard in molecular imprinting, recent developments have expanded the variety of employed porogens accompanied by notable improvements in MIP performance. Therefore, this review aims to highlight both traditional and emerging types of porogens used in molecular imprinting, their influence on polymer properties and sorption performance, and their application across various sensing and extraction applications.

Measuring the Mechanical Properties of Insulin: A Potential Solution to Overcoming the Challenges of Real-Time, Point-of-Care Insulin Sensing

It is well established real-time, point-of-care capabilities for insulin sensing would provide valuable insight to enhance diabetes management and care in the human body. However, such suitable technology has not yet been developed or commercialized. While not comprehensive, this commentary provides a concise summary of the motivation and challenges of developing real-time, point-of-care insulin sensing technology and offers some comments on current approaches. This short research analysis presents a new perspective on the problem and introduces a future potential solution via measuring the mechanical properties of insulin and discusses the challenges foreseen in the feasibility of this proposed solution.

Preparation of Temperature-Sensitive Molecularly Imprinted Cryogel for Specific Recognition of Proteins

In order to maintain the stability of the structure of protein molecules and improve the recognition during the separation process, molecular imprinting technology is combined with freeze polymerization to synthesize molecular imprinting cryogels (MICs). This study uses bovine serum albumin (BSA) as a template protein, low critical cosolubility temperature (LCST)-type ionic liquids as temperature-sensitive functional monomers, imidazole ionic liquids, and acrylamides as auxiliary functional monomers to prepare MICs with specific recognition, temperature sensitivity, interpenetrating macroporous structure, and large specific surface area. The MICs prepared at freezing temperature have uniform macroporous structures and good mechanical properties, which is conducive to the improvement of the mass transfer and adsorption capacities. Due to the advantages, the MIC reaches the adsorption equilibrium within 125 min with a saturated adsorption capacity of 741.5 mg g-1 and an imprinting factor of 1.65. Their static and dynamic adsorption behaviors are more in line with the Langmuir model and the quasi-secondary kinetic model, respectively. In addition, the MIC has obvious temperature sensitivity, and the maximum adsorption amount is reached at 37 °C. The separation factor (relative to cytochrome c, bovine blood hemoglobin, and lysozyme) of the MICs for BSA is up to 1.39. Repeatability experiments reveal that the adsorption capacity of molecularly imprinted cryogels is retained at 87% after five adsorption-desorption cycles, indicating excellent recyclability and potential for practical application.

High-density microneedle array-based wearable electrochemical biosensor for detection of insulin in interstitial fluid

The development of point-of-care wearable devices capable of measuring insulin concentration has the potential to significantly improve diabetes management and life quality of diabetic patients. However, the lack of a suitable point-of-care device for personal use makes regular insulin level measurements challenging, in stark contrast to glucose monitoring. Herein, we report an electrochemical transdermal biosensor that utilizes a high-density polymeric microneedle array (MNA) to detect insulin in interstitial fluid (ISF). The biosensor consists of gold-coated polymeric MNA modified with an insulin-selective aptamer, which was used for extraction and electrochemical quantification of the insulin in ISF. In vitro testing of biosensor, performed in artificial ISF (aISF), showed high selectivity for insulin with a linear response between 0.01 nM and 4 nM (sensitivity of ∼65 Ω nM-1), a range that covers both the physiological and the pathological concentration range. Furthermore, ex vivo extraction and quantification of insulin from mouse skin showed no impact on the biosensor's linear response. As a proof of concept, an MNA-based biosensing platform was utilized for the extraction and quantification of insulin on live mouse skin. In vivo application showed the ability of MNs to reach ISF, extract insulin from ISF, and perform electrochemical measurements sufficient for determining insulin levels in blood and ISF. We believe that our MNA-based biosensing platform based on extraction and quantification of the biomarkers will help move insulin assays from traditional laboratory approaches to personalized point-of-care settings.

Recent progress on nanomaterial-based electrochemical sensors for glucose detection in human body fluids

In the modern age, half of the population is facing various chronic illnesses due to glucose maintenance in the body, major causes of fatality and inefficiency. The early identification of glucose plays a crucial role in medical treatment and the food industry, particularly in diabetes diagnosis. In the past few years, non-enzymatic electrochemical glucose sensors have received a lot of interest for their ability to identify glucose levels accurately. Electrochemical biosensors are developing as a propitious solution for personalized health monitoring due to their accuracy, specificity, and affordability. This review article provides an observation of a variety of non-enzymatic glucose sensor resources, such as carbon nanomaterials, noble metals gold and silver, transition metal and their oxides, and porous material composites. Moreover, basic knowledge of the reaction mechanism of enzymatic and nonenzymatic glucose sensors are outlined and recent advancements in glucose sensors applications to various human body biofluids such as sweat, tears, urine, saliva, and blood are presented. Finally, this review summarizes electrochemical sensors for glucose detection in human body fluids, the challenges they faced, and their solutions.

A Low-Cost Electrochemical Cell Sensor Based on MWCNT-COOH/α-Fe2O3 for Toxicity Detection of Drinking Water Disinfection Byproducts

The disinfection of drinking water is essential for eliminating pathogens and preventing waterborne diseases. However, this process generates various disinfection byproducts (DBPs), which toxicological research indicates can have detrimental effects on living organisms. Moreover, the safety of these DBPs has not been sufficiently assessed, underscoring the need for a comprehensive evaluation of their toxic effects and associated health risks. Compared to traditional methods for studying the toxicity of pollutants, emerging electrochemical sensing technologies offer advantages such as simplicity, speed, and sensitivity, presenting an effective means for toxicity research on pollutants. However, challenges remain in this field, including the need to improve electrode sensitivity and reduce electrode costs. In this study, a pencil graphite electrode (PGE) was modified with carboxylated multi-walled carbon nanotubes (MWCNT-COOH) and nano-iron (III) oxide (α-Fe2O3) to fabricate a low-cost electrode with excellent electrocatalytic performance for cell-active substances. Subsequently, a novel cellular electrochemical sensor was constructed for the sensitive detection of the toxicity of three drinking water DBPs. The half inhibitory concentration (IC50) values of 2-chlorophenylacetonitrile (2-CPAN), 3-chlorophenylacetonitrile (3-CPAN), and 4-chlorophenylacetonitrile (4-CPAN) for HepG2 cells were 660.69, 831.76, and 812.83 µM, respectively. This study provides technical support and scientific evidence for the toxicity detection and safety assessment of emerging contaminants.

SERS-Based Aptamer Sensing Strategy for Diabetes Biomarker Detection

Accurate detection of glucose and insulin is crucial for early diagnosis, classification, and timely prevention of diabetes. In this study, we present a novel surface-enhanced Raman scattering (SERS) aptasensor for glucose and insulin detection. The SERS aptasensor is composed of gold bipyramidal nanoparticles (Au BPs), SH-aptamer-methylene blue (MB), and thiolated polyethylene glycol (SH-PEG). As a SERS substrate, the Au BPs provide abundant "hot spots" for the aptasensor to detect target molecules with reasonable sensitivity. One end of the aptamer is modified with a thiol group to facilitate chemical immobilization of SH-aptamer-MB via the Au-S bond, while the other end is functionalized with MB as a probe molecule. SH-PEG is used to block nonspecific adsorption. Glucose and insulin are specifically trapped by SH-aptamer-MB and cause conformational changes in SH-aptamer-MB, which in turn induce changes in the SERS signal of the modified MB, allowing detection of glucose and insulin. Finally, we validated the usefulness of this method on saliva samples and obtained satisfactory results. The proposed aptasensor exhibits strong selectivity and reliable sensitivity and provides an effective strategy for using SERS in disease biomarkers detection.

Biomimetic Cell Membrane Layers for the Detection of Insulin and Glucagon

The growing need for reliable and rapid insulin testing to enhance glycemic management has spurred intensive exploration of new insulin-binding bioreceptors and innovative biosensing platforms for detecting this hormone, along with glucagon, in biological samples. Here, by leveraging the native protein receptors on the HepG2 cell membrane, we construct a simple and chemical-free biomimetic molecular recognition layer for the detection of insulin and glucagon. Unlike traditional affinity sensors, which require lengthy surface modifications on the electrochemical transducers and use of two different capture antibodies to recognize each analyte, this new biomimetic sensing strategy employs a simple drop-casting of a natural cell membrane recognition layer onto the electrochemical transducer. This approach allows for the concurrent capture and detection of both insulin and glucagon. We investigate the presence of insulin and glucagon receptors on the HepG2 cell membrane and demonstrate its multiplexing bioelectronic sensing capabilities through the binding of the captured insulin and glucagon to enzyme-tagged signaling antibodies. This new molecular recognition layer offers highly sensitive simultaneous detection of insulin and glucagon under decentralized conditions, holding considerable promise for the management of diabetes and the development of diverse biomimetic diagnostic platforms.

Simultaneous and Rapid Detection of Glucose and Insulin: Coupling Enzymatic and Aptamer-Based Assays

Diabetes management demands precise monitoring of key biomarkers, particularly insulin (I) and glucose (G). Herein, we present a bioelectronic chip device that enables the simultaneous detection of I and G in biofluids within 2 min. This dual biosensor chip integrates aptamer-based insulin sensing with enzymatic glucose detection on a single platform, employing a four-electrode sensor chip. The insulin voltammetric sensor employs a G-quadraplex methylene-blue-modified aptamer, while the amperometric biocatalytic glucose sensor utilizes a second-generation mediator-based approach. Simultaneous reagent-less sensing of I and G has been achieved by addressing key challenges. These include combining different surface chemistries, assay formats, and detection principles at closely spaced working electrodes and the substantially different concentration levels of the I and G targets. An attractive analytical performance, with no apparent crosstalk, is demonstrated for the simultaneous detection of millimolar G concentrations and picomolar I concentrations in single microliter serum or saliva sample droplets. This dual biosensor offers rapid, cost-effective, and reliable monitoring, addressing the unmet need for integrated multiplexed diabetes biomarker detection in decentralized settings. Such integration of enzymatic and aptamer-based bioassays could greatly expand the scope of decentralized testing in healthcare beyond diabetes care.

Progress in nanoparticle-based electrochemical biosensors for hormone detection

Hormones are chemical messengers that regulate a wide range of physiological processes including metabolism, development, growth, reproduction and mood. The concentration of hormones that orchestrate the numerous bodily functions is very low (1 nM or less). Efforts have been made to develop highly sensitive tools to detect them. This review represents a critical comparison between different types of nanoparticle-based electrochemical biosensors for the detection of various hormones, namely cortisol, sex hormones (estradiol, progesterone, testosterone), insulin, thyroid-stimulating hormone (TSH) and growth hormone (GH). The electrochemical biosensors investigated for each hormone are first divided on the basis of the biological fluid tested for their detection, and successively on the basis of the electrochemical transducer utilized in the device (voltammetric or impedimetric). Focus is placed on the nanoparticles employed and the successive electrode modification developed in order to improve detection sensitivity and specificity and biosensor stability. Limit of detection (LOD), linear range, reproducibility and possibility of regeneration for continuous reuse are also investigated and compared. The review also addresses the recent trends in the development of wearable biosensors and point-of-care testing for hormone detection in clinical diagnostics useful for endocrinology research, and the future perspectives regarding the integration of nanomaterials, microfluidics, near field communication (NFC) technology and portable devices.

Development of an electrochemical impedance spectroscopy immunosensor for insulin monitoring employing pyrroloquinoline quinone as an ingestible redox probe

Contemporary electrochemical impedance spectroscopy (EIS)-based biosensors face limitations in their applicability for in vivo measurements, primarily due to the necessity of using a redox probe capable of undergoing oxidation and reduction reactions in solution. Although previous investigations have demonstrated the effectiveness of EIS-based biosensors in detecting various target analytes using potassium ferricyanide as a redox probe, its unsuitability for blood or serum measurements, attributed to its inherent toxicity, poses a significant challenge. In response to this challenge, our study adopted a unique approach, focusing on the use of ingestible materials, by exploring naturally occurring substances within the body, with a specific emphasis on pyrroloquinoline quinone (PQQ). Following an assessment of PQQ's electrochemical attributes, we conducted a comprehensive series of EIS measurements. This involved the thorough characterization of the sensor's evolution, starting from the bare electrode and progressing to the immobilization of antibodies. The sensor's performance was then evaluated through the quantification of insulin concentrations ranging from 1 pM to 100 nM. A single frequency was identified for insulin measurements, offering a pathway for potential in vivo applications by combining PQQ as a redox probe with EIS measurements. This innovative approach holds promise for advancing the field of in vivo biosensing based on the EIS method.

Preparation of Hydrophobic Cryogel Containing Hydroxyoxime Extractant and Its Extraction Properties of Cu(Ⅱ)

Hydrophobic cryogels with monolithic supermacropores based on poly-trimethylolpropane trimethacrylate (pTrim) containing 1-(2-Hydroxyl-5-nonyphenyl)ethanone oxime (LIX84-I) were successfully prepared by a cryo-polymerization technique using organic solvents with freezing points between room temperature and around 0 °C as solvents. The prepared cryogels were characterized in terms of macroscopic shape and porous structure. The cryogels had a monolithic supermacroporous structure and high contents of LIX84-I depending on the added amount of the extractant to the monomer solution. The amount of LIX84-I impregnated in the cryogel had a linear relationship with the added amount of LIX84-I in the monomer solution for cryo-polymerization. Cu(II) in the aqueous solution was immediately adsorbed into the cryogel containing LIX84-I.

Wearable Insulin Biosensors for Diabetes Management: Advances and Challenges

We present a critical review of the current progress in wearable insulin biosensors. For over 40 years, glucose biosensors have been used for diabetes management. Measurement of blood glucose is an indirect method for calculating the insulin administration dosage, which is critical for insulin-dependent diabetic patients. Research and development efforts aiming towards continuous-insulin-monitoring biosensors in combination with existing glucose biosensors are expected to offer a more accurate estimation of insulin sensitivity, regulate insulin dosage and facilitate progress towards development of a reliable artificial pancreas, as an ultimate goal in diabetes management and personalised medicine. Conventional laboratory analytical techniques for insulin detection are expensive and time-consuming and lack a real-time monitoring capability. On the other hand, biosensors offer point-of-care testing, continuous monitoring, miniaturisation, high specificity and sensitivity, rapid response time, ease of use and low costs. Current research, future developments and challenges in insulin biosensor technology are reviewed and assessed. Different insulin biosensor categories such as aptamer-based, molecularly imprinted polymer (MIP)-based, label-free and other types are presented among the latest developments in the field. This multidisciplinary field requires engagement between scientists, engineers, clinicians and industry for addressing the challenges for a commercial, reliable, real-time-monitoring wearable insulin biosensor.

Molecularly Imprinted Polymer-Based Sensors for the Detection of Skeletal- and Cardiac-Muscle-Related Analytes

Molecularly imprinted polymers (MIPs) are synthetic polymers with specific binding sites that present high affinity and spatial and chemical complementarities to a targeted analyte. They mimic the molecular recognition seen naturally in the antibody/antigen complementarity. Because of their specificity, MIPs can be included in sensors as a recognition element coupled to a transducer part that converts the interaction of MIP/analyte into a quantifiable signal. Such sensors have important applications in the biomedical field in diagnosis and drug discovery, and are a necessary complement of tissue engineering for analyzing the functionalities of the engineered tissues. Therefore, in this review, we provide an overview of MIP sensors that have been used for the detection of skeletal- and cardiac-muscle-related analytes. We organized this review by targeted analytes in alphabetical order. Thus, after an introduction to the fabrication of MIPs, we highlight different types of MIP sensors with an emphasis on recent works and show their great diversity, their fabrication, their linear range for a given analyte, their limit of detection (LOD), specificity, and reproducibility. We conclude the review with future developments and perspectives.

Insulin detection in diabetes mellitus: challenges and new prospects

Tremendous progress has been made towards achieving tight glycaemic control in individuals with diabetes mellitus through the use of frequent or continuous glucose measurements. However, in patients who require insulin, accurate dosing must consider multiple factors that affect insulin sensitivity and modulate insulin bolus needs. Accordingly, an urgent need exists for frequent and real-time insulin measurements to closely track the dynamic blood concentration of insulin during insulin therapy and guide optimal insulin dosing. Nevertheless, traditional centralized insulin testing cannot offer timely measurements, which are essential to achieving this goal. This Perspective discusses the advances and challenges in moving insulin assays from traditional laboratory-based assays to frequent and continuous measurements in decentralized (point-of-care and home) settings. Technologies that hold promise for insulin testing using disposable test strips, mobile systems and wearable real-time insulin-sensing devices are discussed. We also consider future prospects for continuous insulin monitoring and for fully integrated multisensor-guided closed-loop artificial pancreas systems.